Shenzhenshimanman Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Shenzhenshimanman Technology Co., Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include NFHRUKRE and VNBIRUJKT. The owner is based in Shenzhen.

522 Bldg B, #14, Jinxiu East Road

XiuxinCommunity, KengziSt, PingshanDist

Shenzhen 518110 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NFHRUKRE
NFHRUKRE
Registered 2024
VNBIRUJKT
VNBIRUJKT
Registered 2024

Trademark Classifications

Shenzhenshimanman Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhenshimanman Technology Co., Ltd have?

Shenzhenshimanman Technology Co., Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhenshimanman Technology Co., Ltd file in?

Shenzhenshimanman Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhenshimanman Technology Co., Ltd's most well-known trademarks?

Shenzhenshimanman Technology Co., Ltd's registered trademark portfolio includes well-known marks such as NFHRUKRE and VNBIRUJKT. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhenshimanman Technology Co., Ltd's trademark registration success rate?

Shenzhenshimanman Technology Co., Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.